Literature DB >> 26637232

Use of Polyvinyl Alcohol as a Solubility-Enhancing Polymer for Poorly Water Soluble Drug Delivery (Part 1).

Chris Brough1,2, Dave A Miller3, Justin M Keen3, Shawn A Kucera4, Dieter Lubda4, Robert O Williams5.   

Abstract

Polyvinyl alcohol (PVAL) has not been investigated in a binary formulation as a concentration-enhancing polymer owing to its high melting point/high viscosity and poor organic solubility. Due to the unique attributes of the KinetiSol® dispersing (KSD) technology, PVAL has been enabled for this application and it is the aim of this paper to investigate various grades for improvement of the solubility and bioavailability of poorly water soluble active pharmaceutical ingredients. Solid amorphous dispersions were created with the model drug, itraconazole (ITZ), at a selected drug loading of 20%. Polymer grades were chosen with variation in molecular weight and degree of hydroxylation to determine the effects on performance. Differential scanning calorimetry, powder X-ray diffraction, polarized light microscopy, size exclusion chromatography, and dissolution testing were used to characterize the amorphous dispersions. An in vivo pharmacokinetic study in rats was also conducted to compare the selected formulation to current market formulations of ITZ. The 4-88 grade of PVAL was determined to be effective at enhancing solubility and bioavailability of itraconazole.

Entities:  

Keywords:  KinetiSol® dispersing; PVAL 4-88; itraconazole; polyvinyl alcohol; solid amorphous dispersions

Mesh:

Substances:

Year:  2015        PMID: 26637232      PMCID: PMC4766132          DOI: 10.1208/s12249-015-0458-y

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  47 in total

1.  Quantification of crystallinity in substantially amorphous materials by synchrotron X-ray powder diffractometry.

Authors:  Cletus Nunes; Arumugam Mahendrasingam; Raj Suryanarayanan
Journal:  Pharm Res       Date:  2005-08-31       Impact factor: 4.200

Review 2.  Current perspectives in dissolution testing of conventional and novel dosage forms.

Authors:  Shirzad Azarmi; Wilson Roa; Raimar Löbenberg
Journal:  Int J Pharm       Date:  2006-10-06       Impact factor: 5.875

Review 3.  Amorphous solid dispersions and nano-crystal technologies for poorly water-soluble drug delivery.

Authors:  Chris Brough; R O Williams
Journal:  Int J Pharm       Date:  2013-06-07       Impact factor: 5.875

4.  Effect of characteristics of compounds on maintenance of an amorphous state in solid dispersion with crospovidone.

Authors:  Yusuke Shibata; Makiko Fujii; Makiko Kokudai; Shinobu Noda; Hideko Okada; Masuo Kondoh; Yoshiteru Watanabe
Journal:  J Pharm Sci       Date:  2007-06       Impact factor: 3.534

5.  Evaluation of hypromellose acetate succinate (HPMCAS) as a carrier in solid dispersions.

Authors:  Fumié Tanno; Yuichi Nishiyama; Hiroyasu Kokubo; Sakaé Obara
Journal:  Drug Dev Ind Pharm       Date:  2004-01       Impact factor: 3.225

6.  Preparation and characterization of fusion processed solid dispersions containing a viscous thermally labile polymeric carrier.

Authors:  Justin R Hughey; Justin M Keen; Dave A Miller; Chris Brough; James W McGinity
Journal:  Int J Pharm       Date:  2012-08-31       Impact factor: 5.875

7.  Preparation of carbamazepine-Soluplus solid dispersions by hot-melt extrusion, and prediction of drug-polymer miscibility by thermodynamic model fitting.

Authors:  Jelena Djuris; Ioannis Nikolakakis; Svetlana Ibric; Zorica Djuric; Kyriakos Kachrimanis
Journal:  Eur J Pharm Biopharm       Date:  2013-01-18       Impact factor: 5.571

8.  Characterization of solid dispersions of itraconazole and hydroxypropylmethylcellulose prepared by melt extrusion, Part II.

Authors:  Karel Six; Hugo Berghmans; Christian Leuner; Jennifer Dressman; Kristof Van Werde; Jules Mullens; Luc Benoist; Mireille Thimon; Laurent Meublat; Geert Verreck; Jef Peeters; Marcus Brewster; Guy Van den Mooter
Journal:  Pharm Res       Date:  2003-07       Impact factor: 4.200

9.  A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS.

Authors:  L Mu; S S Feng
Journal:  J Control Release       Date:  2003-01-09       Impact factor: 9.776

10.  Characterization of solid dispersions of itraconazole and hydroxypropylmethylcellulose prepared by melt extrusion--Part I.

Authors:  Geert Verreck; Karel Six; Guy Van den Mooter; Lieven Baert; Jef Peeters; Marcus E Brewster
Journal:  Int J Pharm       Date:  2003-01-30       Impact factor: 5.875

View more
  12 in total

1.  Pharmaceutical Thermal Processing.

Authors:  Feng Zhang; Michael A Repka
Journal:  AAPS PharmSciTech       Date:  2016-02-09       Impact factor: 3.246

2.  Synergistic Effect of Polyvinyl Alcohol and Copovidone in Itraconazole Amorphous Solid Dispersions.

Authors:  Kamil Wlodarski; Feng Zhang; Tongzhou Liu; Wieslaw Sawicki; Thomas Kipping
Journal:  Pharm Res       Date:  2018-01-05       Impact factor: 4.200

3.  Investigating the performance of drug delivery system of fluconazole made of nano-micro fibers coated on cotton/polyester fabric.

Authors:  Dariush Semnani; Mehran Afrashi; Farzaneh Alihosseini; Parvin Dehghan; Mehrnoosh Maherolnaghsh
Journal:  J Mater Sci Mater Med       Date:  2017-09-27       Impact factor: 3.896

4.  Transdermal Delivery of Kidney-Targeting Nanoparticles Using Dissolvable Microneedles.

Authors:  Nirmalya Tripathy; Jonathan Wang; Madelynn Tung; Claire Conway; Eun Ji Chung
Journal:  Cell Mol Bioeng       Date:  2020-06-01       Impact factor: 2.321

Review 5.  The Need for Restructuring the Disordered Science of Amorphous Drug Formulations.

Authors:  Khadijah Edueng; Denny Mahlin; Christel A S Bergström
Journal:  Pharm Res       Date:  2017-05-18       Impact factor: 4.200

6.  Opportunities for Successful Stabilization of Poor Glass-Forming Drugs: A Stability-Based Comparison of Mesoporous Silica Versus Hot Melt Extrusion Technologies.

Authors:  Felix Ditzinger; Daniel J Price; Anita Nair; Johanna Becker-Baldus; Clemens Glaubitz; Jennifer B Dressman; Christoph Saal; Martin Kuentz
Journal:  Pharmaceutics       Date:  2019-11-04       Impact factor: 6.321

7.  Innovations in Thermal Processing: Hot-Melt Extrusion and KinetiSol® Dispersing.

Authors:  Deck Khong Tan; Daniel A Davis; Dave A Miller; Robert O Williams; Ali Nokhodchi
Journal:  AAPS PharmSciTech       Date:  2020-11-08       Impact factor: 3.246

8.  3D printing of a wearable personalized oral delivery device: A first-in-human study.

Authors:  Kun Liang; Simone Carmone; Davide Brambilla; Jean-Christophe Leroux
Journal:  Sci Adv       Date:  2018-05-09       Impact factor: 14.136

9.  Impact of HPMCAS on the Dissolution Performance of Polyvinyl Alcohol Celecoxib Amorphous Solid Dispersions.

Authors:  Marius Monschke; Karl G Wagner
Journal:  Pharmaceutics       Date:  2020-06-11       Impact factor: 6.321

10.  Topical green tea formulation with anti-hemorrhagic and antibacterial effects.

Authors:  Fatemeh Kalalinia; Nafise Amiri; Niloufar Mehrvarzian; Bibi Sedigheh Fazly Bazzaz; Mehrdad Iranshahi; Azadeh Shahroodi; Sepideh Arabzadeh; Mohammadreza Abbaspour; Shapour Badiee Aaval; Jebrail Movaffagh
Journal:  Iran J Basic Med Sci       Date:  2020-08       Impact factor: 2.699

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.